Effect of Vildagliptin and Metformin on endothelial function, low grade inflammation and oxidative stress in newly diagnosed treatment naive type -2 diabetes mellitus

Trial Profile

Effect of Vildagliptin and Metformin on endothelial function, low grade inflammation and oxidative stress in newly diagnosed treatment naive type -2 diabetes mellitus

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Jul 2017

At a glance

  • Drugs Metformin (Primary) ; Vildagliptin (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jul 2017 New trial record
    • 20 May 2017 Results presented at the 24th European Congress on Obesity
    • 20 May 2017 Results presented at the 24th European Congress on Obesity
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top